Page last updated: 2024-10-28

guanfacine and Bilateral Headache

guanfacine has been researched along with Bilateral Headache in 2 studies

Guanfacine: A centrally acting antihypertensive agent with specificity towards ADRENERGIC ALPHA-2 RECEPTORS.

Research Excerpts

ExcerptRelevanceReference
" Trials of amphetamines, atomoxetine, bupropion, clonidine, guanfacine, methylphenidate, and modafinil with a placebo arm and reporting data on headache as an adverse event, were included."2.82Headache in ADHD as comorbidity and a side effect of medications: a systematic review and meta-analysis. ( Banaschewski, T; Bölte, S; Buitelaar, JK; Coghill, D; Cortese, S; Häge, A; Hohmann, S; Jonsson, U; Nobel Norrman, H; Pan, PY; Şahpazoğlu Çakmak, SS, 2022)
"Guanfacine is a noradrenergic agonist that is believed to improve symptoms of attention-deficit/hyperactivity disorder (ADHD) through selective actions at alpha2A-adrenoceptors in the prefrontal cortex."2.73Long-term, open-label extension study of guanfacine extended release in children and adolescents with ADHD. ( Biederman, J; Donahue, J; Lyne, A; McBurnett, K; Melmed, RD; Patel, A, 2008)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Pan, PY1
Jonsson, U1
Şahpazoğlu Çakmak, SS1
Häge, A1
Hohmann, S1
Nobel Norrman, H1
Buitelaar, JK1
Banaschewski, T1
Cortese, S1
Coghill, D1
Bölte, S1
Biederman, J1
Melmed, RD1
Patel, A1
McBurnett, K1
Donahue, J1
Lyne, A1

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Efficacy of Pharmacologic Management of ADHD in Children and Youth With Autism Spectrum Disorder[NCT05916339]Phase 4500 participants (Anticipated)Interventional2023-10-01Not yet recruiting
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Reviews

1 review available for guanfacine and Bilateral Headache

ArticleYear
Headache in ADHD as comorbidity and a side effect of medications: a systematic review and meta-analysis.
    Psychological medicine, 2022, Volume: 52, Issue:1

    Topics: Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Central Nervous System Sti

2022

Trials

1 trial available for guanfacine and Bilateral Headache

ArticleYear
Long-term, open-label extension study of guanfacine extended release in children and adolescents with ADHD.
    CNS spectrums, 2008, Volume: 13, Issue:12

    Topics: Adolescent; Adrenergic alpha-Agonists; Attention Deficit Disorder with Hyperactivity; Blood Pressure

2008